{"id":8395,"date":"2015-02-24T18:01:40","date_gmt":"2015-02-24T17:01:40","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=8395"},"modified":"2015-02-24T19:40:24","modified_gmt":"2015-02-24T18:40:24","slug":"eli-lilly-ceo-lechleiter-societa-non-e-vendita-anche-se-fa-gola-molti","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/eli-lilly-ceo-lechleiter-societa-non-e-vendita-anche-se-fa-gola-molti\/","title":{"rendered":"Eli Lilly: CEO Lechleiter, the company is not for sale even if it is tempting for many"},"content":{"rendered":"

"Bringing two companies that have a problem creates a group with a problem twice as big, cutting costs through thousands of layoffs is a recipe that doesn't work"<\/em><\/p>\n

A24-Red \u2013 Borsa Italiana<\/a><\/p>\n

\"\"(Il Sole 24 Ore Radiocor) \u2013 New York, February 24 \u2013 Eli Lilly, the fifth largest American pharmaceutical company, is not for sale. The managing director reiterated this in an interview with the Financial Times John Lechleiter<\/strong>, explaining that they have examined large-scale combinations of other groups and that they have understood that "joining two companies that have a problem creates a group with a problem twice as big, cutting costs through thousands of layoffs is a recipe that works".<\/p>\n

That said, Eli Lilly is considered by experts to be an obvious target for a takeover: with a market capitalization of nearly 80 billion, it could be tempted by giants like Pfizer, while companies like Valeant could be interested in the R&D savings generated by a potential deal. Lechleiter spoke of the company's "structural defenses", such as the fact that the largest shareholder, with a 12% stake, is the charitable foundation Lilly Endowment and the fact that the law of the state of Indiana, where Eli Lilly is based , prohibits hostile takeovers.<\/p>\n

(RADIOCOR) 24-02-15 15:26:46 (0347) 5 NNNN<\/p>\n

Related news:\u00a0P<\/a>illegal removal in USA. The complaint of 6 former ISF, all fired<\/a><\/i><\/p>\n

Editor's note: John C. Lechleiter<\/strong> Ph.D Chairman, Chief Executive Officer and President, Eli Lilly and Company, received total compensation in fiscal 2013 of\u00a0$ 11.217.000<\/strong><\/p>\n

\"Current\u00a0Stock exchange quotation<\/p>","protected":false},"excerpt":{"rendered":"

“Unire due societa’ che hanno un problema crea un gruppo con un problema due volte piu’ grande, tagliare costi tramite migliaia di licenziamenti e’ una ricetta che non funziona” A24-Red – Borsa Italiana (Il Sole 24 Ore Radiocor) – New York, 24 feb – Eli Lilly, quinta maggiore societa’ farmaceutica americana, non e’ in vendita. …<\/p>","protected":false},"author":4,"featured_media":7311,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[47,51],"class_list":["post-8395","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-big-pharma","tag-compenso-top-manager"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/8395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=8395"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/8395\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/7311"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=8395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=8395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=8395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}